The University of Chicago Header Logo

Connection

Anita S. Chong to Tumor Necrosis Factor-alpha

This is a "connection" page, showing publications Anita S. Chong has written about Tumor Necrosis Factor-alpha.
Connection Strength

0.599
  1. Active immunotherapy for TNF-mediated inflammation using self-assembled peptide nanofibers. Biomaterials. 2017 Dec; 149:1-11.
    View in: PubMed
    Score: 0.119
  2. Stimulation of IFN-gamma, TNF-alpha, and TNF-beta secretion in IL-2-activated T cells: costimulatory roles for LFA-1, LFA-2, CD44, and CD45 molecules. Cell Immunol. 1992 Oct 01; 144(1):69-79.
    View in: PubMed
    Score: 0.084
  3. Ability of cell-sized beads bearing tumor cell membrane proteins to stimulate LAK cells to secrete interferon-gamma and tumor necrosis factor-alpha. Cell Immunol. 1991 Apr 15; 134(1):96-110.
    View in: PubMed
    Score: 0.076
  4. Regulation of tumor necrosis factor secretion in leukocytes from alpha-1-antitrypsin deficient humans. Immunol Invest. 1990 Oct-Dec; 19(5-6):453-61.
    View in: PubMed
    Score: 0.073
  5. Phenotypic analyses of lymphokine-activated killer cells that release interferon gamma and tumor necrosis factor alpha. Cancer Immunol Immunother. 1990; 31(4):255-9.
    View in: PubMed
    Score: 0.070
  6. Tumor targets stimulate IL-2 activated killer cells to produce interferon-gamma and tumor necrosis factor. J Immunol. 1989 Mar 15; 142(6):2133-9.
    View in: PubMed
    Score: 0.066
  7. IFN-gamma induces cell growth inhibition by Fas-mediated apoptosis: requirement of STAT1 protein for up-regulation of Fas and FasL expression. Cancer Res. 1998 Jul 01; 58(13):2832-7.
    View in: PubMed
    Score: 0.031
  8. Improved viability of hepatic allografts from fasted donors is associated with decreased peripheral TNF activity. J Surg Res. 1995 Mar; 58(3):337-43.
    View in: PubMed
    Score: 0.025
  9. Phenotypic and functional analysis of lymphokine-activated killer (LAK) cell clones. Ability of CD3+, LAK cell clones to produce interferon-gamma and tumor necrosis factor upon stimulation with tumor targets. Cancer Immunol Immunother. 1989; 29(4):270-8.
    View in: PubMed
    Score: 0.016
  10. The portosystemic shunt protects liver against ischemic reperfusion injury. Transplantation. 1999 Oct 15; 68(7):958-63.
    View in: PubMed
    Score: 0.009
  11. Protective effect of ischemic preconditioning on liver preservation-reperfusion injury in rats. Transplantation. 1998 Jul 27; 66(2):152-7.
    View in: PubMed
    Score: 0.008
  12. Granulocyte colony-stimulating factor immunomodulation in the rat cardiac transplantation model. Transplantation. 1996 Apr 15; 61(7):1122-5.
    View in: PubMed
    Score: 0.007
  13. Inactivation of Kupffer cells after prolonged donor fasting improves viability of transplanted hepatic allografts. Hepatology. 1995 Oct; 22(4 Pt 1):1236-42.
    View in: PubMed
    Score: 0.006
  14. Modification of the clonogenic assay for the detection of lymphokine activated killer cell activity. J Immunol Methods. 1990 Mar 27; 128(1):119-26.
    View in: PubMed
    Score: 0.004
  15. Cytostatic and cytotoxic activity of lymphokine-activated killer cell supernatants. Cancer Immunol Immunother. 1989; 30(1):65-70.
    View in: PubMed
    Score: 0.004
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.